BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31307634)

  • 1. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.
    He M; Liu Z; Lin Y; Wan J; Li J; Xu K; Wang Y; Jin Z; Tian J; Xue H
    Eur J Radiol; 2019 Aug; 117():102-111. PubMed ID: 31307634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a CT radiomics nomogram for preoperative prediction of Ki-67 index in pancreatic ductal adenocarcinoma: a two-center retrospective study.
    Li Q; Song Z; Li X; Zhang D; Yu J; Li Z; Huang J; Su K; Liu Q; Zhang X; Tang Z
    Eur Radiol; 2024 May; 34(5):2934-2943. PubMed ID: 37938382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of Pancreatic Ductal Adenocarcinoma.
    He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
    Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
    Bian Y; Guo S; Jiang H; Gao S; Shao C; Cao K; Fang X; Li J; Wang L; Ma C; Zheng J; Jin G; Lu J
    Cancer Imaging; 2022 Jan; 22(1):4. PubMed ID: 34991733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.
    Li K; Yao Q; Xiao J; Li M; Yang J; Hou W; Du M; Chen K; Qu Y; Li L; Li J; Wang X; Luo H; Yang J; Zhang Z; Chen W
    Cancer Imaging; 2020 Jan; 20(1):12. PubMed ID: 32000852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
    Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
    Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
    Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
    Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CT Radiomics-Based Risk Score for Preoperative Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma.
    Zhou Y; Wang J; Zhang SL; Wang H; Yan Y; Qi X; Chen S; Chen FM
    Ann Surg Oncol; 2023 Feb; 30(2):1206-1216. PubMed ID: 36264518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
    Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
    Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
    Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
    Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics model-based algorithm for preoperative prediction of pancreatic ductal adenocarcinoma grade.
    Tikhonova VS; Karmazanovsky GG; Kondratyev EV; Gruzdev IS; Mikhaylyuk KA; Sinelnikov MY; Revishvili AS
    Eur Radiol; 2023 Feb; 33(2):1152-1161. PubMed ID: 35986774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
    Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R
    Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tumor heterogeneity: Differentiation of periampullary neoplasms based on CT whole-lesion histogram analysis.
    Lu J; Hu D; Tang H; Hu X; Shen Y; Li Z; Peng Y; Kamel I
    Eur J Radiol; 2019 Jun; 115():1-9. PubMed ID: 31084752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT radiomics signature: a potential biomarker for fibroblast activation protein expression in patients with pancreatic ductal adenocarcinoma.
    Meng Y; Yu J; Zhu M; Zhou J; Li N; Liu F; Zhang H; Fang X; Li J; Feng X; Wang L; Jiang H; Lu J; Shao C; Bian Y
    Abdom Radiol (NY); 2022 Aug; 47(8):2822-2834. PubMed ID: 35451626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
    Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
    Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.